A carregar...
What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology?
The introduction of biosimilars of biological agents for which the patents and exclusivity periods have expired is an attractive way of reducing healthcare spending through price competition with the reference product. In oncology, biosimilars of growth factors for supportive therapy were the pionee...
Na minha lista:
| Publicado no: | Breast Care (Basel) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger GmbH
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6465746/ https://ncbi.nlm.nih.gov/pubmed/31019437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000496834 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|